section name header

Pronunciation ⬇

myoo-PEER-oh-sin

Classifications ⬆ ⬇

Therapeutic Classification: anti-infectives

Indications ⬆ ⬇

REMS

Action ⬆ ⬇

  • Inhibits bacterial protein synthesis.
Therapeutic effects:
  • Inhibition of bacterial growth and reproduction.

Spectrum:

Pharmacokinetics ⬆ ⬇

Absorption: Minimal systemic absorption.

Distribution: Remains in the stratum corneum after topical use for prolonged periods of time (72 hr).

Metabolism/Excretion: Metabolized in the skin, removed by desquamation.

Half-Life: 17–36 min.

Time/Action Profile ⬆ ⬇

(anti-infective effect)

ROUTEONSETPEAKDURATION
Topical‡unknown3–5 days72 hr



‡Resolution of lesions.

Contraind./Precautions ⬆ ⬇

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects ⬆ ⬇

Derm: burning, itching, pain, stinging

Interactions ⬆ ⬇

Drug-drug:

Route/Dosage ⬆ ⬇

Availability ⬆ ⬇

(Generic available)

Assessment ⬆ ⬇

Implementation ⬆ ⬇

Patient/Family Teaching ⬆ ⬇

Evaluation/Desired Outcomes ⬆ ⬇

US Brand Names ⬆ ⬇

Bactroban

Code ⬆

NDC Code